Project Grant HT94252510661
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$660K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15213, USA
Similar Awards
The Defense Health Agency awarded a $1,117,352 Project Grant to Trustees of Boston University's Boston University Medical Campus to develop a novel and practical intervention for detoxification of per- and polyfluoroalkyl substances (PFAS) in humans. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports the university's research to transform health care for Service Members and the public through innovative biomedical research. As part of the...
This Project Grant award of $555,100.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research at the University of Illinois. The goal is to investigate testicular germ cell tumors as a potential sentinel indicator of per- and polyfluoroalkyl substances (PFAS) exposure. The award period runs from August 1, 2025 to July 31, 2028. The university has extensive experience in federal research grants and...
This $701,121 federal Project Grant award from the Department of Defense's Defense Health Agency, issued under the Military Medical Research and Development program (CFDA 12.420), supports research on the ovarian-disrupting effects and mechanisms of per- and polyfluoroalkyl substances (PFAS). The project is being conducted by Rutgers, The State University of New Jersey's RBHS-School of Nursing over a 3-year period from September 2023 to September 2026. The research aims to develop a better...
The University of Illinois was awarded a $798,912 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to investigate how PFAS (per- and polyfluoroalkyl substances) exposures can reprogram prostate stem cells and drive carcinogenesis and cancer progression. The 3-year project, running from July 1, 2023 to June 30, 2026, will advance scientific understanding of how environmental PFAS exposures may...
This Project Grant award from the Department of the Navy's Office of Naval Research (ONR) under the Basic and Applied Scientific Research program (CFDA 12.300) provides $300,000 to Multiscale Technologies Inc. to conduct research on the AI/ML-assisted advancement of degradation science of per- and polyfluoroalkyl substances (PFAS) on 2-dimensional nanoconfining substrates. The research aims to advance scientific understanding and potential technological solutions related to this class of...
This federal Project Grant award, provided by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program, supports research to define the neurotoxic and neurodevelopmental health risks of per- and polyfluoroalkyl substances (PFAS). The $546,350 award, effective January 13, 2025 through October 31, 2029, aims to characterize the mechanisms by which PFAS affect brain development and function. Key objectives include defining PFAS uptake...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $573,416 project grant to The Geneva Foundation to conduct a study titled "PRE-DIAGNOSTIC SERUM CONCENTRATIONS OF PER- AND POLYFLUOROALKYL SUBSTANCES AND RISK OF TESTICULAR GERM CELL TUMORS AMONG ACTIVE-DUTY SERVICEMEN." The 3-year grant, which began on Sep 30, 2023, will support research investigating the relationship between exposure to per- and polyfluoroalkyl substances...
The University of Pittsburgh was awarded a $1,572,933 federal Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The grant, effective January 1, 2025 through December 31, 2028, supports advanced biomedical research aimed at "Targeting Lysosomal Pathways to Improve Host Immunity Post Coronaviral Infections." This research aligns with the program's objective to transform healthcare for military service members,...
The Department of the Air Force Materiel Command Research Laboratory awarded $198,290 under the Air Force Defense Research Sciences Program (CFDA 12.800) to Carnegie Mellon University from March 1, 2022 to February 28, 2023. The Project Grant funding will support Carnegie Mellon University's development of a scanning ion conductance microscopy-enabled atomic force microscope for research on peptide nucleic acid-based nanostructures at biotic and abiotic interfaces. The Air Force Defense Research...
This $520,259 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research at Carnegie Mellon University to develop a liquid biopsy-based approach for predicting pathological complete response in breast cancer patients. The project aims to leverage extracellular vesicles and advanced sequencing techniques to enable ultrasensitive detection of breast cancer-specific genetic mutations. As a...